The Effectiveness of Hybrid Peel (99% Spongilla spicules and 0.5% Beta Hydroxy Acids) in Treating Acne-Prone Skin: A Presentation of 4 Cases

Background: Acne vulgaris (AV) is a prevalent dermatological disorder, affecting over 90% of adolescents and persisting into adulthood in around 12–14% of individuals. Although this condition is generally regarded as mild, it imposes a significant economic and psychological burden on society. In the treatment of acne and acne lesions, chemical exfoliation is a frequently used procedure. Spongilla spicules have been used as dispersed microneedles to improve the penetration of various therapeutics and nanoparticles by disrupting the skin barrier. No research has discussed the effectiveness of hybrid peel contains 99% spongilla spicules and 0.5% Beta Hydroxy Acids (BHA) in treating acne-prone skin. Case Report: Four subjects, aged 17-36, with varying degrees of acne, received the hybrid peel treatment. The dose administered during a single session was 3 mL of BHA 0.5% serum with 0.3 grams of Micro Spicules (silica) applied topically. Subsequently, a cell booster serum, face and neck mask, and sunscreen with SPF 50 are administered. Patients were subjected to three treatment sessions, with a two-week interval between sessions. The evaluation was conducted by observing the patient's facial skin condition and capturing photographs before and after three treatment sessions. The evaluation results indicated a considerable improvement in all subjects' acne and skin texture. Conclusion: The hybrid peel, which contained 99% spongilla spicules and 0.5% beta hydroxy acids, effectively treated acne-prone skin.